Immutep Quote - IMMP

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.91

Bid

1.80

Offer

2.00

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

277.822M

Previous Close

1.91

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

145,456,785

Dividend Yield

PE Ratio

-1.06

Earnings Per Share (EPS)

-0.29

Revenue

Net Profit

-42.72M

Immutep Ltd. is a clinical stage biotechnology company developing novel LAG-3 immunotherapy for cancer and autoimmune disease. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesse... Immutep Ltd. is a clinical stage biotechnology company developing novel LAG-3 immunotherapy for cancer and autoimmune disease. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesses LAG-3's unique ability to stimulate or suppress the immune response. Immutep's lead clinical candidate, eftilagimod alpha ('efti'), is a soluble LAG-3 protein and first-in-class MHC Class II agonist that stimulates both innate and adaptive immunity to fight cancer. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.immutep.com

Headquarters

Sydney, New South Wales, Aus

Founded

Immutep Ltd is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IMMP. The last closing price for Immutep was US$1.91. Over the last year, Immutep shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Immutep currently has 145,456,785 shares in issue. The market capitalisation of Immutep is US$277.82 million. Immutep has a price to earnings ratio (PE ratio) of -1.06.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

IMMP - Frequently Asked Questions (FAQ)

What is the current Immutep share price?

The current share price of Immutep is US$ 1.91

How many Immutep shares are in issue?

Immutep has 145,456,785 shares in issue

What is the market cap of Immutep?

The market capitalisation of Immutep is USD 277.82M

What is the 1 year trading range for Immutep share price?

Immutep has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Immutep?

The price to earnings ratio of Immutep is -1.06

What is the reporting currency for Immutep?

Immutep reports financial results in AUD

What is the latest annual profit for Immutep?

The latest annual profit of Immutep is AUD -42.72M

What is the registered address of Immutep?

The registered address for Immutep is LEVEL 12, 95 PITT STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Immutep website address?

The website address for Immutep is www.immutep.com

Which industry sector does Immutep operate in?

Immutep operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SAGSAG Holdings Ltd	US$ 1.465 (117.04%)	1.21M
OPTNOptiNose Inc	US$ 8.80 (46.67%)	17
DSPViant Technology Inc	US$ 17.99 (46.38%)	2
IDYAIDEAYA Biosciences Inc	US$ 23.99 (31.74%)	5
AGMHAGM Group Holdings Inc	US$ 0.09 (25.00%)	1.57M
ZCARZoomcar Holdings Inc	US$ 0.2204 (-28.19%)	8.27k
ELVNEnliven Therapeutics Inc	US$ 16.01 (-23.36%)	1
AKBAAkebia Therapeutics Inc	US$ 2.24 (-21.13%)	2.91k
NEHCNew Era Helium Inc	US$ 2.00 (-20.32%)	5
VRPXVirpax Pharmaceuticals Inc	US$ 0.0932 (-14.50%)	18.42k
AGMHAGM Group Holdings Inc	US$ 0.09 (25.00%)	1.57M
SAGSAG Holdings Ltd	US$ 1.465 (117.04%)	1.21M
BTOGBit Origin Ltd	US$ 0.318 (20.05%)	1.12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 8.55 (5.04%)	807.05k
IMGCIMG Inc	US$ 0.5949 (23.94%)	295.13k